Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Fund for Scientific Research in Rheumatology

Koning Boudewijnstichting

The Fund for scientific research in rheumatology launches a call for research into rheumatic diseases. The research should focus especially on clinical and multidisciplinary or multicenter programs, either in academic or non-academic Belgian institutions, that respond to a clearly identified need of patients and/or caregivers.

Projects that are open to collaborations with other interested centers and which cannot easily be supported through other existing national or international programs are especially invited. For clinical research, the relevance of the project and the potential impact of the results on diagnosis/treatment/quality of care have to be clearly defined.

Seeding money for innovative translational or basic research can also be requested, in a preparative phase for more established funding opportunities.

A total budget of € 150.000 has been allocated to this call, in order to support different projects (target amount per project: € 30.000 max). Maximum 20% of this total budget can be dedicated to translational research.

Who is it for?

The call is open to researchers/research teams within academic or non-academic Belgian institutions. Trainees in rheumatology and young rheumatologists are particularly encouraged to submit an application. The application should be formally supported by a confirmed researcher (e.g. holds PhD or clear research experience). Laureates of previous calls may reapply if they have submitted all activity reports related to the previous call(s) as required by the agreement. Collaborative projects involving researchers as well as clinicians and patients are encouraged. Multicenter research is encouraged (i.e. with a proof of collaboration between researchers from different centers regarding the content of the research, inclusion of patients and logistic cooperation).

Specialties

Rheumatology

Eligibility Requirements

The call is open to

- all health professionals and researchers in Belgium with an interest in clinical or translational rheumatology research.

- Trainees in rheumatology and young rheumatologists are particularly encouraged to submit an application.

- Collaborative projects involving researchers as well as clinicians and patients are encouraged.

- Laureates of previous calls may reapply if they have submitted all activity reports related to the previous call(s) as required by the agreement.

- The main applicant may not apply to this call more than once as main applicant but may apply as a co-applicant on more than one application.

Eligible Countries:

Belgium

Sponsor Details

Sponsor Institute/Organizations: Koning Boudewijnstichting

Sponsor Type: Corporate/Non-Profit

Address: Rue Brederode 21 1000 Brussels, Belgium

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity